Form 4: Allegion SVP and General Counsel Joseph Blasko Receives Significant Equity Grant
Insider Transaction Report
Allegion plc's Senior Vice President and General Counsel, Joseph Blasko, was granted 1,525 restricted stock units and stock options for 5,966 ordinary shares, both vesting over three years starting July 2, 2026.
Summary
- Joseph Blasko, Senior Vice President and General Counsel of Allegion plc, was granted equity awards on July 2, 2025.
- Blasko acquired 1,525 ordinary shares in the form of restricted stock units (RSUs) at a price of $0.
- These RSUs are scheduled to vest in equal annual installments on July 2, 2026, July 2, 2027, and July 2, 2028.
- Additionally, Blasko was granted stock options for 5,966 ordinary shares with an exercise price of $147.62 per share.
- The stock options will also vest in equal annual installments on July 2, 2026, July 2, 2027, and July 2, 2028, and have an expiration date of July 2, 2035.
- Following these transactions, Joseph Blasko directly beneficially owns 1,525 ordinary shares and 5,966 stock options.
Sentiment
Score: 7
Explanation: The grant of equity awards to a senior executive is generally a positive signal, indicating commitment to retention and performance alignment, though it's a standard compensation practice rather than a significant strategic announcement.
Positives
- The grant of restricted stock units and stock options aligns the executive's interests with long-term shareholder value creation.
- Equity compensation is a common incentive for retaining key management personnel and encouraging long-term commitment.
Future Outlook
The vesting schedule for the granted restricted stock units and stock options extends through July 2, 2028, indicating a long-term incentive structure for the executive and aligning their interests with the company's future performance.
Industry Context
This transaction is a routine executive equity grant, common across industries to incentivize and retain senior leadership by aligning their financial interests with the company's long-term performance and strategic goals.
Related Party Transactions
- The grant of equity awards to Joseph Blasko, a Senior Vice President and General Counsel, constitutes a related party transaction as it involves compensation to a key management personnel.
Stakeholder Impact
- Shareholders: The grant of equity awards aims to align executive incentives with shareholder value creation, though it represents a potential future dilution as RSUs vest and options are exercised.
- Management: Joseph Blasko's compensation package is enhanced, providing long-term incentives and fostering retention.
Next Steps
- Vesting of restricted stock units in equal annual installments on July 2, 2026, July 2, 2027, and July 2, 2028.
- Vesting of stock options in equal annual installments on July 2, 2026, July 2, 2027, and July 2, 2028.
- Potential exercise of stock options by their expiration date of July 2, 2035.
Key Dates
| Date | Description |
|---|---|
| 07/02/2025 | Date of transaction for the grant of restricted stock units and stock options. |
| 07/07/2025 | Date the Form 4 was signed by the attorney-in-fact. |
| 07/02/2026 | First vesting installment date for both restricted stock units and stock options. |
| 07/02/2027 | Second vesting installment date for both restricted stock units and stock options. |
| 07/02/2028 | Third and final vesting installment date for both restricted stock units and stock options. |
| 07/02/2035 | Expiration date for the granted stock options. |
Keywords
Allegion plc, ALLE, Joseph Blasko, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Options, Equity Grant, Executive Compensation, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.